Pcdh9 | protocadherin 9
Physiological systems
20 / 24 physiological systems tested
3 Significantly impacted by the knock-out
Homeostasis/metabolism Behavior/neurological Mortality/aging
17 No significant impact
4 Not tested
Gene metrics:7Significant phenotypes
0Associated diseases
Expression examined in:48Adult tissues
50Embryo tissues
| increased vertical activity | 1 supporting dataset | Pcdh9tm1.1(KOMP)Vlcg | heterozygote | Early adult | 4.94x10-10 | ||
| hyperactivity | 9 supporting datasets | Pcdh9tm1.1(KOMP)Vlcg | heterozygote | Early adult | 1.13x10-18 | ||
| decreased grip strength | 4 supporting datasets | Pcdh9tm1.1(KOMP)Vlcg | heterozygote | Early adult | 2.64x10-7 | ||
| increased circulating aspartate transaminase level | 1 supporting dataset | Pcdh9tm1.1(KOMP)Vlcg | heterozygote | Early adult | 9.6x10-6 | ||
| increased circulating bilirubin level | 1 supporting dataset | Pcdh9tm1.1(KOMP)Vlcg | heterozygote | Early adult | 1.2x10-5 | ||
| preweaning lethality, incomplete penetrance | 1 supporting dataset | Pcdh9tm1.1(KOMP)Vlcg | homozygote | Early adult | N/A * | ||
| increased circulating phosphate level | 1 supporting dataset | Pcdh9tm1.1(KOMP)Vlcg | heterozygote | Early adult | 6.12x10-5 |
| | | | | | | | | | |
External links
No external links available for Pcdh9.
All available products are supplied via our member's centres or partnerships. When ordering a product from the IMPC you will be redirected to one of their websites or prompted to start an email.